Exploiting an epigenetic resistance mechanism to PI3-kinase inhibition in leukemic stem cells

Abstract Acquired non-genetic resistance mechanisms to existing therapies contribute to poor outcomes for acute myeloid leukemia (AML) patients, and the inability to target leukemic stem cells (LSCs) can lead to relapse. To overcome these challenges, we tested whether LSCs have dependencies on PI3- kinase (PI3K). We found that LSCs are susceptible to isoform-selective targeting of PI3K and are particularly dependent on the p110 alpha isoform of PI3K. We discovered that PI3K inactivation leads to dynamic changes in EZH2/PRC2 function in leukemic cells, and we uncovered downregulation of EZH2 protein levels as an adaptive resistance mechanism in response to PI3K inhibition. We found that PI3K inhibition in AML cells can lead to compensatory upregulation of EZH1 , and that EZH1 knockdown can sensitize AML cells to PI3K inhibition. We leveraged this resistance mechanism by combining a PI3K inhibitor with an EZH1/2 dual inhibitor, which successfully overcomes the acquired resistance and leads to sustained targeting of AML cells ex vivo and in murine AML and PDX models in vivo. This study identifies a promising novel therapeutic regimen for targeting LSCs in AML.

Authors

Institutions

Publication Details

Journal
Leukemia
Published
2026-09-28
DOI
https://doi.org/10.1038/s41375-026-03145-4
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Exploiting an epigenetic resistance mechanism to PI3-kinase inhibition in leukemic stem cells

Mark Soto, Linde A. Miles, Aditi Shastri, Seiya Kitamura et al.
Leukemia
Acute Myeloid Leukemia Research
article

Exploiting an epigenetic resistance mechanism to PI3-kinase inhibition in leukemic stem cells

Mark Soto, Linde A. Miles, Aditi Shastri, Seiya Kitamura, Shira G. Glushakow-Smith, Shayda Hemmati, Kira Gritsman, Simone Sidoli, Imit Kaur, Ulrich G. Steidl, Swathi-Rao Narayanagari, Amit K. Verma, Ellen Angeles, Aaliyah Battle, Samarpana Chakraborty, Melissa Tracy, Rotila Hyka, Jayaram Vankudoth, Taneisha Sinclair, Kristina Ames
article en

Abstract

Abstract Acquired non-genetic resistance mechanisms to existing therapies contribute to poor outcomes for acute myeloid leukemia (AML) patients, and the inability to target leukemic stem cells (LSCs) can lead to relapse. To overcome these challenges, we tested whether LSCs have dependencies on PI3- kinase (PI3K). We found that LSCs are susceptible to isoform-selective targeting of PI3K and are particularly dependent on the p110 alpha isoform of PI3K. We discovered that PI3K inactivation leads to dynamic changes in EZH2/PRC2 function in leukemic cells, and we uncovered downregulation of EZH2 protein levels as an adaptive resistance mechanism in response to PI3K inhibition. We found that PI3K inhibition in AML cells can lead to compensatory upregulation of EZH1 , and that EZH1 knockdown can sensitize AML cells to PI3K inhibition. We leveraged this resistance mechanism by combining a PI3K inhibitor with an EZH1/2 dual inhibitor, which successfully overcomes the acquired resistance and leads to sustained targeting of AML cells ex vivo and in murine AML and PDX models in vivo. This study identifies a promising novel therapeutic regimen for targeting LSCs in AML.

Leukemia
Cincinnati Children's Hospital Medical Center (US), Albert Einstein College of Medicine (US), Montefiore Medical Center (US), Montefiore Hospital (GB), Montefiore Einstein Comprehensive Cancer Center, University of Cincinnati (US)
No poverty
Openalex Percentile: Top 11%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.